Back to Search

SUSAN EPSTEIN, PH.D.

PH.D.

Clinical Neuropsychologist

NPI: 1437367638Individual

Specialties, Licenses & Credentials

Clinical NeuropsychologistPrimary

Clinical Neuropsychologist

Code: 103G00000X

016655(NY)
Psychologist

Psychologist

Code: 103T00000X

016655(NY)
Clinical Psychologist

Psychologist — Clinical

Code: 103TC0700X

016655(NY)
Clinical Child & Adolescent Psychologist

Psychologist — Clinical Child & Adolescent

Code: 103TC2200X

016655(NY)

Research & Publications (20)

Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells.
PMID 19284328·J Ocul Pharmacol Ther·2009
4-observational
Is treatment of early postmenopausal women with bisphosphonates justified?
PMID 17504359·Int J Clin Pract·2007
6-review
Susceptibility testing of clinical isolates of pseudomonas aeruginosa to levofloxacin, moxifloxacin, and gatifloxacin as a guide to treating pseudomonas ocular infections.
PMID 16974157·Eye Contact Lens·2006
4-observational
Ibandronate treatment for osteoporosis: rationale, preclinical, and clinical development of extended dosing regimens.
PMID 16527003·Curr Osteoporos Rep·2006
6-review
Oral ibandronate in the management of postmenopausal osteoporosis: review of upper gastrointestinal safety.
PMID 16522358·Maturitas·2006
6-review
The roles of bone mineral density, bone turnover, and other properties in reducing fracture risk during antiresorptive therapy.
PMID 15757020·Mayo Clin Proc·2005
6-review
Disintegration/dissolution profiles of copies of Fosamax (alendronate).
PMID 14687450·Curr Med Res Opin·2003
4-observational
Recurrent ocular herpes simplex keratitis following excimer laser photorefractive keratectomy in a rabbit model.
PMID 11352456·CLAO J·2001
7-preclinical
Effect of the interaction of parathyroid hormone and cyclosporine a on bone mineral metabolism in the rat.
PMID 11353952·Calcif Tissue Int·2001
4-observational
Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): additional results from the Monthly Oral Therapy With Ibandronate For Osteoporosis Intervention (MOTION) study.
PMID 19446148·Clin Ther·2009
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
3524 78TH ST APT B11
JACKSON HEIGHTS, NY 11372

Locations (2)

Practice Location

3524 78TH ST APT B11, JACKSON HEIGHTS, NY
(464) 503-6336

Practice Location

845 N BROADWAY, WHITE PLAINS, NY
(914) 761-0600

Quick Facts

NPI
1437367638
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
4
Locations
2
Publications
20

Are you this provider?

Claim Your Profile